Literature DB >> 18539722

A comparison of invasive versus noninvasive full-time mechanical ventilation in Duchenne muscular dystrophy.

P Soudon1, M Steens, M Toussaint.   

Abstract

The aim of this study was to compare morbidity and causes of death in a series of 42 Duchenne patients receiving full-time mechanical ventilation either by tracheostomy (TR, n = 16 or by noninvasive methods (noninvasive ventilation [NIV], n = 26). At inclusion for a 5-year observation period (2002-2006), TR and NIV patients were 32.7 and 27 years old, respectively. A program of follow-up with similar ventilation devices, techniques of respiratory physiotherapy, and drugs was applied to all the patients [TR + NIV]. Ages and respiratory characteristics at death and causes of death were comparable between groups. Morbidity was worse in TR compared with NIV patients; mucus hypersecretion and tracheal injuries were more frequent, whereas loss of weight and need for gastric feeding appeared less frequent in the TR group. Because noninvasive techniques avoid the severe complications associated with TR with comparable mortality, the authors support the use of noninvasive interfaces as default choice when assisted ventilation is required for daytime use.

Entities:  

Mesh:

Year:  2008        PMID: 18539722     DOI: 10.1177/1479972308088715

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  13 in total

Review 1.  Mouthpiece ventilation and complementary techniques in patients with neuromuscular disease: A brief clinical review and update.

Authors:  Tiago Pinto; Michelle Chatwin; Paolo Banfi; Joao Carlos Winck; Antonello Nicolini
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

2.  Mouthpiece ventilation: Individualized patient care is the key to success.

Authors:  Adam Ogna; Frederic Lofaso
Journal:  Chron Respir Dis       Date:  2016-08-20       Impact factor: 2.444

3.  Intermittent daytime mouthpiece ventilation successfully augments nocturnal non-invasive ventilation, controlling ventilatory failure and maintaining patient independence.

Authors:  Karen Ward; Verity Ford; Helen Ashcroft; Robert Parker
Journal:  BMJ Case Rep       Date:  2015-07-09

4.  Twenty-four hour noninvasive ventilation in Duchenne muscular dystrophy: a safe alternative to tracheostomy.

Authors:  Doug A McKim; Nadia Griller; Carole LeBlanc; Andrew Woolnough; Judy King
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

5.  Liberation and mortality outcomes in pediatric long-term ventilation: A qualitative systematic review.

Authors:  Candice M Foy; Monica L Koncicki; Jeffrey D Edwards
Journal:  Pediatr Pulmonol       Date:  2020-08-12

Review 6.  Benefits of interventions for respiratory secretion management in adult palliative care patients-a systematic review.

Authors:  Juliano Ferreira Arcuri; Ebun Abarshi; Nancy J Preston; Jenny Brine; Valéria Amorim Pires Di Lorenzo
Journal:  BMC Palliat Care       Date:  2016-08-09       Impact factor: 3.234

7.  Long-term non-invasive ventilation in muscular dystrophy.

Authors:  W Kinnear; J Colt; L Watson; P Smith; L Johnson; S Burrows; M Sovani; A Khanna; P Maddison; A Wills
Journal:  Chron Respir Dis       Date:  2016-07-08       Impact factor: 2.444

8.  Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the Neuromuscular Centre Ulm.

Authors:  Kurt H Wollinsky; Bernd Kutter; Peter M Geiger
Journal:  Acta Myol       Date:  2012-12

9.  Management of Ventilatory Insufficiency in Neuromuscular Patients Using Mechanical Ventilator Supported by the Korean Government.

Authors:  Seong-Woong Kang; Won Ah Choi; Han Eol Cho; Jang Woo Lee; Jung Hyun Park
Journal:  J Korean Med Sci       Date:  2016-04-14       Impact factor: 2.153

10.  Dysphagia in Duchenne muscular dystrophy: practical recommendations to guide management.

Authors:  Michel Toussaint; Zoe Davidson; Veronique Bouvoie; Nathalie Evenepoel; Jurn Haan; Philippe Soudon
Journal:  Disabil Rehabil       Date:  2016-01-05       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.